More than 1,800 consumers are starting to receive refunds for purchasing two dietary supplements that the Federal Trade Commission (FTC) alleged were deceptively marketed as treatments for non-alcoholic fatty liver disease (NAFLD). In April 2021, two companies, BASF SE and DIEM Labs, agreed to pay more than $416,000 to the FTC to settle charges that they deceptively marketed ... Read More